Literature DB >> 1927491

The mechanism of irritative nystagmus and paralytic nystagmus. A histochemical study of the guinea pig's vestibular organ and an autoradiographic study of the vestibular nuclei.

J Hozawa1, K Fukuoka, S Usami, K Ikeno, E Fukushi, H Shinkawa, K Hozawa.   

Abstract

To establish the difference of mechanism between irritative and paralytic nystagmus, alterations of Na-K-ATPase and succinic dehydrogenase activity in the vestibular sensorineural elements were investigated for 20 guinea pigs, and glucose uptake of the vestibular nuclei for 13 guinea pigs were measured by the [14C]-2-deoxy-D-glucose method. Irritative and paralytic nystagmus were experimentally provoked by introducing K+ into the perilymphatic space. From the results it was concluded that irritative nystagmus is provoked by increased excitability of vestibular sensory cells, while paralytic nystagmus is provoked by decreased excitability. However, the direction of nystagmus was eventually decided by the tonus imbalance between the bilateral vestibular nuclei. The ipsilateral vestibular nucleus was predominant during irritative nystagmus, while the contralateral vestibular nucleus was predominant during paralytic nystagmus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1927491     DOI: 10.3109/00016489109131349

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  3 in total

1.  Balance dysfunction and recovery after surgery for superior canal dehiscence syndrome.

Authors:  Kristen L Janky; M Geraldine Zuniga; John P Carey; Michael Schubert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-08

2.  Intra-Attack Vestibuloocular Reflex Changes in Ménière's Disease.

Authors:  Dario A Yacovino; John B Finlay
Journal:  Case Rep Otolaryngol       Date:  2016-11-28

Review 3.  Usefulness of Video Head Impulse Test Results in the Identification of Meniere's Disease.

Authors:  Brahim Kaci; Mujda Nooristani; Tamara Mijovic; Maxime Maheu
Journal:  Front Neurol       Date:  2020-10-29       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.